& Ohta, H
Mechanistic experiments showed elevated populations of cDC1 and cross-presentation and long-lasting anti-tumor immunity indicated by a substantial rise in cDC1 populations and effector memory CD8 + T cells
[11] [14] Urgent assessment is needed for hot flashes accompanied by systemic symptoms (fever, unexplained weight loss), abnormal vaginal bleeding, or atypical features suggesting alternative diagnoses
For example, pharmacists were seeing Saxenda, Wegovy, and Zepbound being prescribed for patients who did not have a body mass index (BMI) of 30 kg/m2 or a BMI of 27 kg/m2 with at least one weight associated comorbidity
[2] Additionally, GLP-1 agonists may be prescribed for individuals with type 2 diabetes who have coexisting conditions such as atherosclerosis, heart failure, or chronic kidney disease, as these medications have demonstrated potential benefits beyond glycemic control
However, they are still subject to state board of pharmacy oversight and must comply with USP compounding standards and Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, according to the Alliance for Pharmacy Compounding